Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calaminici

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Histopathology|February 28, 2023
Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortiumYasodha Natkunam, Daphne de Jong, Pedro Farinha, et al.
Blood|March 31, 2021
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomasJames Heward, Lola Konali, Annalisa D'Avola, et al.
Haematologica|April 16, 2017
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker ConsortiumWendy B C Stevens, Matias Mendeville, Robert Redd, et al.
Histopathology|March 21, 2013
Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroupsTeresa Marafioti, Christiane Copie-Bergman, Maria Calaminici, et al.
Nature Genetics|December 24, 2013
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphomaJessica Okosun, Csaba Bödör, Jun Wang, et al.
Histopathology|September 15, 2022
Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implicationsMaria Joao Baptista, Gustavo Tapia, Ana-María Muñoz-Marmol, et al.
Blood Advances|August 10, 2022
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphomaFindlay Bewicke-Copley, Koorosh Korfi, Shamzah Araf, et al.
Cancer Cytopathology|July 7, 2023
Digital Examination of LYmph node CYtopathology Using the Sydney system (DELYCYUS): An international, multi-institutional studyAlessandro Caputo, Filippo Fraggetta, Pasquale Cretella, et al.
Nature Genetics|December 23, 2015
Recurrent mTORC1-activating RRAGC mutations in follicular lymphomaJessica Okosun, Rachel L Wolfson, Jun Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2019
Prognostic Significance of <i>MYC</i> Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker ConsortiumAndreas Rosenwald, Susanne Bens, Ranjana Advani, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Histopathology|February 28, 2023
Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortiumYasodha Natkunam, Daphne de Jong, Pedro Farinha, et al.
Blood|March 31, 2021
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomasJames Heward, Lola Konali, Annalisa D'Avola, et al.
Haematologica|April 16, 2017
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker ConsortiumWendy B C Stevens, Matias Mendeville, Robert Redd, et al.
Histopathology|March 21, 2013
Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroupsTeresa Marafioti, Christiane Copie-Bergman, Maria Calaminici, et al.
Nature Genetics|December 24, 2013
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphomaJessica Okosun, Csaba Bödör, Jun Wang, et al.
Histopathology|September 15, 2022
Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implicationsMaria Joao Baptista, Gustavo Tapia, Ana-María Muñoz-Marmol, et al.
Blood Advances|August 10, 2022
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphomaFindlay Bewicke-Copley, Koorosh Korfi, Shamzah Araf, et al.
Cancer Cytopathology|July 7, 2023
Digital Examination of LYmph node CYtopathology Using the Sydney system (DELYCYUS): An international, multi-institutional studyAlessandro Caputo, Filippo Fraggetta, Pasquale Cretella, et al.
Nature Genetics|December 23, 2015
Recurrent mTORC1-activating RRAGC mutations in follicular lymphomaJessica Okosun, Rachel L Wolfson, Jun Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2019
Prognostic Significance of <i>MYC</i> Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker ConsortiumAndreas Rosenwald, Susanne Bens, Ranjana Advani, et al.
Pageof 14